Prenetics Global Ltd
PRE7.790USD
-0.210-2.62%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
100.06MCap. mercado
PérdidaP/E TTM
Más Datos de Prenetics Global Ltd Compañía
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Información de la empresa
Símbolo de cotizaciónPRE
Nombre de la empresaPrenetics Global Ltd
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoMr. Joel Neoh
Número de empleados285
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 06
DirecciónUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Ciudad
Bolsa de valoresLondon Stock Exchange
PaísHong Kong
Código postal- -
Teléfono85222109588
Sitio Webhttps://ir.prenetics.com/
Símbolo de cotizaciónPRE
Fecha de salida a bolsaJul 06, 2021
Director ejecutivoMr. Joel Neoh
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Hong Kong
14.27M
46.59%
Taiwan
7.09M
23.16%
The United States
5.51M
18.00%
United Kingdom
2.78M
9.08%
Rest of the world
972.00K
3.17%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 9 de jul
Actualizado: mié., 9 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dennis (Lo Yuk Ming)
8.41%
Genetel Bioventures Ltd
5.36%
Lawrence (Tzang Chi Hung)
4.69%
Eastspring Investments (Singapore) Limited
3.74%
Aspex Management (HK) Limited
3.02%
Other
74.78%
Accionistas
Accionistas
Proporción
Dennis (Lo Yuk Ming)
8.41%
Genetel Bioventures Ltd
5.36%
Lawrence (Tzang Chi Hung)
4.69%
Eastspring Investments (Singapore) Limited
3.74%
Aspex Management (HK) Limited
3.02%
Other
74.78%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
14.52%
Investment Advisor
6.72%
Corporation
5.36%
Hedge Fund
3.13%
Research Firm
2.91%
Investment Advisor/Hedge Fund
0.06%
Other
67.31%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
30
3.75M
32.70%
-1.26M
2025Q1
31
3.72M
35.24%
-295.48K
2024Q4
35
3.71M
34.90%
-336.29K
2024Q3
37
3.69M
34.65%
-448.54K
2024Q2
38
3.76M
35.34%
-535.47K
2024Q1
88
5.56M
55.93%
+1.27M
2023Q4
94
4.17M
42.91%
+30.90K
2023Q3
99
4.01M
43.06%
+108.37K
2023Q2
98
3.11M
36.85%
-918.88K
2023Q1
94
3.14M
40.86%
+44.13K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dennis (Lo Yuk Ming)
962.96K
8.41%
--
--
Apr 24, 2025
Genetel Bioventures Ltd
613.79K
5.36%
--
--
Sep 30, 2024
Lawrence (Tzang Chi Hung)
537.10K
4.69%
--
--
Apr 24, 2025
Eastspring Investments (Singapore) Limited
427.96K
3.74%
--
--
Mar 31, 2025
Aspex Management (HK) Limited
346.15K
3.02%
--
--
Mar 31, 2025
Nomura Securities Co., Ltd.
333.53K
2.91%
+10.58K
+3.27%
Mar 31, 2025
Pacific Alliance Group Asset Management Limited
290.25K
2.53%
-1.00
-0.00%
Nov 27, 2023
Chun (Lo Hoi)
162.62K
1.42%
--
--
Apr 24, 2025
UBS Financial Services, Inc.
26.33K
0.23%
-64.00
-0.24%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
Fecha
Tipo
Relación
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
Nov 01, 2023
Merger
15<1
